| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| beta-Lactamases | 8 | 2018 | 759 | 2.47 | Why? |
| Bacteriological Techniques | 4 | 2018 | 239 | 1.85 | Why? |
| Bacterial Proteins | 9 | 2019 | 1318 | 1.78 | Why? |
| Bacteroides fragilis | 2 | 2017 | 12 | 1.40 | Why? |
| Hong Kong | 23 | 2021 | 3361 | 1.27 | Why? |
| Enterobacteriaceae | 3 | 2018 | 395 | 1.06 | Why? |
| Methicillin-Resistant Staphylococcus aureus | 3 | 2019 | 711 | 0.99 | Why? |
| Genes, Bacterial | 3 | 2019 | 207 | 0.90 | Why? |
| Staphylococcal Infections | 4 | 2019 | 1099 | 0.90 | Why? |
| Escherichia coli | 3 | 2018 | 1547 | 0.86 | Why? |
| Toilet Facilities | 1 | 2021 | 88 | 0.83 | Why? |
| Carbapenems | 5 | 2018 | 343 | 0.83 | Why? |
| Chromosomes, Bacterial | 1 | 2019 | 18 | 0.82 | Why? |
| Staphylococcus lugdunensis | 1 | 2019 | 14 | 0.82 | Why? |
| Anti-Bacterial Agents | 11 | 2021 | 10083 | 0.79 | Why? |
| Genome, Bacterial | 3 | 2019 | 446 | 0.78 | Why? |
| Joint Prosthesis | 1 | 2019 | 20 | 0.77 | Why? |
| Bone Cements | 1 | 2019 | 21 | 0.77 | Why? |
| Bacteroides | 1 | 2017 | 16 | 0.70 | Why? |
| Disk Diffusion Antimicrobial Tests | 1 | 2017 | 36 | 0.69 | Why? |
| Plasmids | 2 | 2018 | 840 | 0.68 | Why? |
| Imipenem | 1 | 2017 | 57 | 0.68 | Why? |
| Joint Diseases | 1 | 2019 | 122 | 0.68 | Why? |
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2017 | 449 | 0.63 | Why? |
| Colitis | 1 | 2019 | 266 | 0.61 | Why? |
| beta-Lactam Resistance | 2 | 2018 | 150 | 0.59 | Why? |
| Microbial Sensitivity Tests | 10 | 2021 | 2886 | 0.59 | Why? |
| Cross Infection | 8 | 2021 | 8675 | 0.58 | Why? |
| Escherichia coli Infections | 2 | 2018 | 348 | 0.57 | Why? |
| Prosthesis-Related Infections | 1 | 2019 | 302 | 0.57 | Why? |
| Hygiene | 1 | 2021 | 987 | 0.53 | Why? |
| Intensive Care Units, Neonatal | 1 | 2019 | 749 | 0.49 | Why? |
| Drug Resistance, Bacterial | 4 | 2018 | 1414 | 0.48 | Why? |
| Public Opinion | 1 | 2021 | 1165 | 0.42 | Why? |
| Pneumococcal Infections | 3 | 2019 | 562 | 0.41 | Why? |
| DNA, Bacterial | 3 | 2019 | 835 | 0.40 | Why? |
| Enterobacteriaceae Infections | 1 | 2016 | 529 | 0.40 | Why? |
| Klebsiella pneumoniae | 1 | 2016 | 658 | 0.40 | Why? |
| Streptococcus pneumoniae | 3 | 2019 | 827 | 0.34 | Why? |
| Community-Acquired Infections | 1 | 2019 | 2328 | 0.32 | Why? |
| Drug Resistance, Multiple, Bacterial | 4 | 2021 | 1115 | 0.32 | Why? |
| Acinetobacter Infections | 2 | 2021 | 273 | 0.31 | Why? |
| Acinetobacter baumannii | 2 | 2021 | 378 | 0.31 | Why? |
| Pneumococcal Vaccines | 3 | 2019 | 571 | 0.29 | Why? |
| Patient Admission | 2 | 2020 | 5250 | 0.27 | Why? |
| Drug Resistance, Microbial | 2 | 2019 | 419 | 0.26 | Why? |
| Environmental Microbiology | 2 | 2019 | 575 | 0.25 | Why? |
| Infection Control | 7 | 2020 | 23131 | 0.25 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 3832 | 0.24 | Why? |
| Asthma | 1 | 2021 | 4383 | 0.24 | Why? |
| Disease Outbreaks | 7 | 2020 | 27595 | 0.23 | Why? |
| Vaccines, Conjugate | 2 | 2019 | 328 | 0.22 | Why? |
| Sequence Analysis, DNA | 3 | 2019 | 2830 | 0.22 | Why? |
| Influenza, Human | 2 | 2020 | 10779 | 0.21 | Why? |
| Mutation | 3 | 2018 | 12376 | 0.21 | Why? |
| Escherichia coli Proteins | 2 | 2018 | 168 | 0.20 | Why? |
| Serogroup | 2 | 2019 | 510 | 0.20 | Why? |
| Ribotyping | 1 | 2019 | 54 | 0.20 | Why? |
| Humerus | 1 | 2019 | 19 | 0.19 | Why? |
| Endopeptidase Clp | 1 | 2018 | 1 | 0.19 | Why? |
| Respiratory Tract Infections | 1 | 2020 | 6817 | 0.19 | Why? |
| Tibia | 1 | 2019 | 72 | 0.18 | Why? |
| Shoulder Joint | 1 | 2019 | 57 | 0.18 | Why? |
| Mycobacterium tuberculosis | 2 | 2018 | 1164 | 0.18 | Why? |
| Femur | 1 | 2019 | 100 | 0.18 | Why? |
| Anesthetists | 1 | 2020 | 186 | 0.18 | Why? |
| Polymerase Chain Reaction | 4 | 2017 | 6740 | 0.18 | Why? |
| Whole Genome Sequencing | 2 | 2019 | 3239 | 0.17 | Why? |
| Debridement | 1 | 2019 | 172 | 0.17 | Why? |
| Bacterial Typing Techniques | 1 | 2019 | 273 | 0.17 | Why? |
| DNA, Ribosomal | 1 | 2017 | 112 | 0.17 | Why? |
| Animal Husbandry | 1 | 2018 | 162 | 0.17 | Why? |
| Antibiotics, Antitubercular | 1 | 2017 | 65 | 0.17 | Why? |
| RNA, Bacterial | 1 | 2017 | 116 | 0.17 | Why? |
| Prosthesis Failure | 1 | 2019 | 195 | 0.17 | Why? |
| beta-Lactamase Inhibitors | 1 | 2018 | 104 | 0.17 | Why? |
| Focus Groups | 1 | 2021 | 811 | 0.16 | Why? |
| Isoniazid | 1 | 2017 | 105 | 0.16 | Why? |
| Symptom Flare Up | 1 | 2020 | 432 | 0.16 | Why? |
| Farms | 1 | 2018 | 269 | 0.16 | Why? |
| Protective Clothing | 1 | 2020 | 468 | 0.16 | Why? |
| Prosthesis Implantation | 1 | 2019 | 261 | 0.16 | Why? |
| Replicon | 1 | 2018 | 232 | 0.16 | Why? |
| Multilocus Sequence Typing | 1 | 2017 | 264 | 0.15 | Why? |
| Porins | 1 | 2016 | 45 | 0.15 | Why? |
| Reoperation | 1 | 2019 | 544 | 0.15 | Why? |
| Organometallic Compounds | 1 | 2018 | 206 | 0.15 | Why? |
| Colistin | 1 | 2018 | 217 | 0.15 | Why? |
| Patients' Rooms | 1 | 2020 | 675 | 0.15 | Why? |
| Carbapenem-Resistant Enterobacteriaceae | 1 | 2017 | 214 | 0.14 | Why? |
| Anesthesia, General | 1 | 2020 | 470 | 0.14 | Why? |
| Rifampin | 1 | 2017 | 276 | 0.14 | Why? |
| Streptococcal Infections | 1 | 2018 | 255 | 0.14 | Why? |
| Support Vector Machine | 1 | 2017 | 330 | 0.14 | Why? |
| Promoter Regions, Genetic | 1 | 2018 | 823 | 0.14 | Why? |
| Observer Variation | 1 | 2017 | 622 | 0.14 | Why? |
| Fomites | 1 | 2020 | 709 | 0.13 | Why? |
| Colon | 1 | 2019 | 669 | 0.13 | Why? |
| RNA, Ribosomal, 16S | 1 | 2017 | 793 | 0.13 | Why? |
| Molecular Epidemiology | 1 | 2019 | 1638 | 0.13 | Why? |
| Respiratory Function Tests | 1 | 2020 | 1755 | 0.12 | Why? |
| Liver Transplantation | 2 | 2019 | 2864 | 0.12 | Why? |
| Air Pollution, Indoor | 1 | 2021 | 816 | 0.12 | Why? |
| Hepacivirus | 2 | 2019 | 1509 | 0.12 | Why? |
| Hand Sanitizers | 1 | 2018 | 397 | 0.12 | Why? |
| Tuberculosis, Multidrug-Resistant | 1 | 2017 | 433 | 0.12 | Why? |
| Humans | 33 | 2021 | 930598 | 0.11 | Why? |
| Virulence | 1 | 2019 | 2172 | 0.11 | Why? |
| Clostridium Infections | 1 | 2019 | 595 | 0.11 | Why? |
| Staphylococcus aureus | 1 | 2018 | 844 | 0.11 | Why? |
| Hepatitis B | 1 | 2019 | 888 | 0.10 | Why? |
| Diagnostic Errors | 1 | 2017 | 865 | 0.10 | Why? |
| Air Microbiology | 1 | 2020 | 1322 | 0.10 | Why? |
| Pandemics | 10 | 2021 | 389249 | 0.10 | Why? |
| Seroconversion | 1 | 2020 | 2515 | 0.10 | Why? |
| Penaeidae | 1 | 2009 | 13 | 0.10 | Why? |
| Airway Management | 1 | 2020 | 1298 | 0.10 | Why? |
| Pneumonia, Viral | 8 | 2020 | 243684 | 0.10 | Why? |
| Bacillus subtilis | 1 | 2009 | 34 | 0.10 | Why? |
| Coronavirus Infections | 8 | 2020 | 253789 | 0.10 | Why? |
| Equipment Contamination | 1 | 2018 | 1308 | 0.10 | Why? |
| Swine | 1 | 2018 | 3352 | 0.09 | Why? |
| Cities | 1 | 2021 | 4937 | 0.09 | Why? |
| Qualitative Research | 1 | 2021 | 4337 | 0.09 | Why? |
| Respiratory Protective Devices | 1 | 2020 | 1637 | 0.09 | Why? |
| High-Throughput Screening Assays | 1 | 2017 | 1783 | 0.09 | Why? |
| Sensitivity and Specificity | 3 | 2017 | 22971 | 0.09 | Why? |
| Tuberculosis, Pulmonary | 1 | 2018 | 1171 | 0.09 | Why? |
| Hand Disinfection | 1 | 2018 | 1671 | 0.09 | Why? |
| Bacteremia | 1 | 2018 | 1372 | 0.09 | Why? |
| Hand Hygiene | 1 | 2018 | 1493 | 0.08 | Why? |
| Gene Expression | 1 | 2018 | 3332 | 0.08 | Why? |
| Female | 15 | 2021 | 380317 | 0.08 | Why? |
| Genomics | 1 | 2019 | 3118 | 0.08 | Why? |
| Hepatitis C | 1 | 2018 | 1514 | 0.08 | Why? |
| Anti-Infective Agents | 1 | 2018 | 1766 | 0.08 | Why? |
| Severe Acute Respiratory Syndrome | 3 | 2020 | 12361 | 0.07 | Why? |
| Nasopharynx | 1 | 2004 | 10224 | 0.07 | Why? |
| Male | 13 | 2021 | 367725 | 0.07 | Why? |
| Serotyping | 1 | 2004 | 154 | 0.07 | Why? |
| Phenotype | 1 | 2016 | 4037 | 0.07 | Why? |
| Hospitals | 2 | 2021 | 11793 | 0.07 | Why? |
| Public Health | 2 | 2020 | 16359 | 0.07 | Why? |
| Virus Shedding | 1 | 2020 | 5834 | 0.06 | Why? |
| Socioeconomic Factors | 1 | 2021 | 8495 | 0.06 | Why? |
| History, 20th Century | 1 | 2009 | 1282 | 0.06 | Why? |
| Population Surveillance | 1 | 2020 | 4967 | 0.06 | Why? |
| Nucleic Acid Amplification Techniques | 1 | 2017 | 3388 | 0.06 | Why? |
| Adolescent | 5 | 2021 | 86841 | 0.06 | Why? |
| Betacoronavirus | 8 | 2020 | 204454 | 0.06 | Why? |
| Travel | 1 | 2021 | 7220 | 0.06 | Why? |
| Middle Aged | 9 | 2021 | 270681 | 0.06 | Why? |
| Child Day Care Centers | 1 | 2004 | 208 | 0.06 | Why? |
| Young Adult | 4 | 2021 | 93724 | 0.06 | Why? |
| Contact Tracing | 2 | 2020 | 8448 | 0.06 | Why? |
| Risk Factors | 3 | 2020 | 71621 | 0.06 | Why? |
| Air Pollution | 1 | 2020 | 3504 | 0.06 | Why? |
| Peptide Hydrolases | 1 | 2009 | 1269 | 0.05 | Why? |
| Probiotics | 1 | 2009 | 694 | 0.05 | Why? |
| Infant, Newborn | 2 | 2019 | 23105 | 0.05 | Why? |
| Workflow | 2 | 2021 | 2373 | 0.05 | Why? |
| Quarantine | 3 | 2021 | 18418 | 0.05 | Why? |
| Students, Medical | 1 | 2019 | 4032 | 0.05 | Why? |
| Mass Screening | 1 | 2020 | 8005 | 0.05 | Why? |
| Case-Control Studies | 1 | 2019 | 17671 | 0.05 | Why? |
| Carrier State | 2 | 2018 | 2100 | 0.05 | Why? |
| Streptococcus gallolyticus | 1 | 2018 | 7 | 0.05 | Why? |
| Sputum | 2 | 2018 | 1720 | 0.05 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2018 | 11367 | 0.05 | Why? |
| Acinetobacter | 1 | 2018 | 58 | 0.04 | Why? |
| Aged, 80 and over | 5 | 2021 | 88759 | 0.04 | Why? |
| Bismuth | 1 | 2018 | 56 | 0.04 | Why? |
| Adult | 7 | 2021 | 244371 | 0.04 | Why? |
| Time Factors | 2 | 2020 | 31397 | 0.04 | Why? |
| China | 4 | 2020 | 50654 | 0.04 | Why? |
| Retrospective Studies | 2 | 2020 | 105322 | 0.04 | Why? |
| Calibration | 1 | 2018 | 307 | 0.04 | Why? |
| Genetic Markers | 1 | 2018 | 318 | 0.04 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 9706 | 0.04 | Why? |
| Algorithms | 2 | 2004 | 7346 | 0.04 | Why? |
| Genotype | 2 | 2018 | 4697 | 0.04 | Why? |
| DNA-Directed RNA Polymerases | 1 | 2017 | 239 | 0.04 | Why? |
| Madin Darby Canine Kidney Cells | 1 | 2018 | 640 | 0.04 | Why? |
| Medical Records | 1 | 2018 | 513 | 0.04 | Why? |
| Peritonitis | 1 | 2018 | 217 | 0.04 | Why? |
| Animals | 4 | 2018 | 78931 | 0.04 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.04 | Why? |
| Child | 3 | 2019 | 70012 | 0.04 | Why? |
| Colonic Neoplasms | 1 | 2018 | 295 | 0.03 | Why? |
| Reference Standards | 1 | 2018 | 1163 | 0.03 | Why? |
| Mass Vaccination | 1 | 2004 | 1101 | 0.03 | Why? |
| Ventilation | 1 | 2021 | 1145 | 0.03 | Why? |
| Aged | 6 | 2021 | 215776 | 0.03 | Why? |
| Aerosols | 2 | 2020 | 5393 | 0.03 | Why? |
| Surveys and Questionnaires | 1 | 2021 | 43792 | 0.03 | Why? |
| Hospitalization | 2 | 2021 | 54280 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Tomography, X-Ray Computed | 1 | 2019 | 25144 | 0.03 | Why? |
| Ships | 1 | 2020 | 1046 | 0.03 | Why? |
| Health Personnel | 2 | 2020 | 29646 | 0.03 | Why? |
| Treatment Outcome | 1 | 2019 | 51732 | 0.03 | Why? |
| Catalytic Domain | 1 | 2018 | 1757 | 0.03 | Why? |
| Communicable Disease Control | 1 | 2021 | 29620 | 0.03 | Why? |
| Crystallography, X-Ray | 1 | 2018 | 2689 | 0.03 | Why? |
| Thorax | 1 | 2020 | 1873 | 0.03 | Why? |
| Zinc | 1 | 2018 | 817 | 0.03 | Why? |
| Dogs | 1 | 2018 | 2529 | 0.03 | Why? |
| Israel | 1 | 2019 | 2751 | 0.03 | Why? |
| Africa | 1 | 2019 | 2986 | 0.03 | Why? |
| Soy Foods | 1 | 2009 | 21 | 0.02 | Why? |
| Child, Preschool | 3 | 2019 | 36283 | 0.02 | Why? |
| Phylogeny | 2 | 2018 | 13341 | 0.02 | Why? |
| Viral Load | 2 | 2020 | 15850 | 0.02 | Why? |
| Communicable Diseases, Emerging | 1 | 2003 | 2523 | 0.02 | Why? |
| Base Sequence | 1 | 2017 | 3581 | 0.02 | Why? |
| Colony Count, Microbial | 1 | 2009 | 177 | 0.02 | Why? |
| Homes for the Aged | 1 | 2018 | 1071 | 0.02 | Why? |
| Mice, Inbred BALB C | 1 | 2018 | 5814 | 0.02 | Why? |
| Japan | 1 | 2020 | 6653 | 0.02 | Why? |
| Prevalence | 2 | 2019 | 25773 | 0.02 | Why? |
| Drug Evaluation, Preclinical | 1 | 2018 | 3347 | 0.02 | Why? |
| Guideline Adherence | 1 | 2018 | 2309 | 0.02 | Why? |
| Colorectal Neoplasms | 1 | 2018 | 1884 | 0.02 | Why? |
| Triage | 1 | 2003 | 7151 | 0.02 | Why? |
| Evolution, Molecular | 1 | 2018 | 3691 | 0.02 | Why? |
| Genetic Variation | 1 | 2018 | 3919 | 0.02 | Why? |
| Molecular Diagnostic Techniques | 1 | 2020 | 4239 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2018 | 9537 | 0.02 | Why? |
| Prospective Studies | 2 | 2018 | 43301 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2018 | 11304 | 0.01 | Why? |
| Gastrointestinal Tract | 1 | 2009 | 1113 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2018 | 10998 | 0.01 | Why? |
| Mice | 1 | 2018 | 21357 | 0.01 | Why? |
| Sex Distribution | 1 | 2003 | 2083 | 0.01 | Why? |
| Infant | 1 | 2019 | 30274 | 0.01 | Why? |
| Critical Care | 1 | 2020 | 14081 | 0.01 | Why? |
| Age Distribution | 1 | 2003 | 3567 | 0.01 | Why? |
| RNA, Viral | 1 | 2018 | 32276 | 0.01 | Why? |
| Survival Analysis | 1 | 2003 | 7592 | 0.01 | Why? |
| Incidence | 1 | 2003 | 25622 | 0.00 | Why? |
| Disease Transmission, Infectious | 1 | 2003 | 9044 | 0.00 | Why? |
| Global Health | 1 | 2003 | 13911 | 0.00 | Why? |
| Risk Assessment | 1 | 2003 | 25439 | 0.00 | Why? |